The New Genetics of Schizophrenia

The largest study conducted of people with schizophrenia has found 83 new gene locations, with some in surprising places. These findings will allow researchers to pursue new theories about what causes schizophrenia and how to treat it. For this study, the researchers looked at the genetic codes of 36,989 people with schizophrenia and 113.075 people …

Read more

Are you or a loved one living with Alzheimer’s disease?

Are you or a loved one living with Alzheimer’s disease? Segal Institute for Clinical Research is currently conducting a clinical research study evaluating the safety and efficacy of an investigational drug for patients with mild to moderate Alzheimer’s disease. To qualify, volunteers must: • Be between the ages of 55 and 85 • Have a …

Read more

No Link between Migraine and Breast Cancer

Relief for millions of women suffering from migraines: researchers have confirmed there is no link between migraines and breast cancer. Lead researcher Rulla Tamimi, an associate professor of medicine at Harvard Medical School, said, “There is no positive association, so there is no reason for concern, and there is no protective effect either.” Previous studies …

Read more

Novel Drug May Lead to Better Treatment for Schizophrenia

Scientists at the Centre for Addiction and Mental Health have identified a novel drug target that could lead to the development of better antipsychotic medications. Currently, treatment for patients with schizophrenia involves taking medications that block or interfere with the action of the neurotransmitter dopamine, which acts on dopamine D2 receptors in the brain. However, …

Read more

Common Migraine Comorbidities

Comorbidities is a term used when two illnesses appear at a greater than coincidental rate in the general population. Researchers have identified common migraine comorbidities as depression, anxiety, stroke, irritable bowel syndrome, epilepsy, and hypertension, which suggests at some level the illnesses are interrelated. To better understand the illness and receive optimal migraine care, identifying …

Read more

There is an Improved Need for Schizophrenia Care

A recent study found that improper drug treatment is given to nearly 40 percent of patients that suffer from their first episode of schizophrenia. The researchers noted that this improper drug treatment can lead to patient’s long-term outcome, since schizophrenia is a chronic treatment, as well as problems that cause patients to stop taking their …

Read more

Imaging Differentiates PTSD and Mild Brain Injury

Right now, it is difficult for clinicians to make a diagnosis between PTSD and mild traumatic brain injury (MTBI) since patients experience similar symptoms and the conditions are unable to be detected by normal structural neuroimaging. However, using hybrid imaging with positron emission tomography and computed tomography (PET/CT), researchers are able to differentiate between the …

Read more

Schizophrenia may stem from Brain Protein Surplus

A gene that is associated with schizophrenia is also associated with brain development, which could help researchers explain the way the disease originates. The overproduction of the NOS1AP gene causes abnormalities in brain structure and faulty connections between nerve cells that prevent them from communicating correctly, says Bonnie Firestein, Ph.D., a Rutgers professor in the …

Read more

Brain Network Found that is Vulnerable to Schizophrenia

Researchers have found a specific brain network that is the last to develop, but first to show signs of neurodegeneration, which is more vulnerable to disorders that emerge in young people, shedding light on conditions such as schizophrenia and the potential genetic and environmental factors that may occur early in life. A team led by …

Read more

Want more information?

Join our
Newsletter!

Be the first to know about our new studies! You can unsubscribe at any time.